Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/30001
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2028-08-30
Colecciones
- INI - Artigos de Periódicos [3460]
Metadatos
Mostrar el registro completo del ítem
LIPID LEVELS IN THE SECOND YEAR OF LIFE AMONG HIV-INFECTED AND HIV-EXPOSED UNINFECTED LATIN AMERICAN CHILDREN
Autor
Afiliación
Pediatric, Adolescent, and Maternal AIDS Branch, CRMC-NICHD-NIH. Bethesda, USA.
Westat. Rockville, Maryland, USA.
Westat. Rockville, Maryland, USA.
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Puericultura e Pediatria. Ribeirão Preto, SP, Brasil.
Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Instituto de Infectologia Emilio Ribas. São Paulo, SP, Brasil.
Hospital Infantil de México Federico Gómez. Ciudad de México City, México.
Westat. Rockville, Maryland, USA.
Westat. Rockville, Maryland, USA.
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Departamento de Puericultura e Pediatria. Ribeirão Preto, SP, Brasil.
Universidade Federal do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Instituto de Infectologia Emilio Ribas. São Paulo, SP, Brasil.
Hospital Infantil de México Federico Gómez. Ciudad de México City, México.
Resumen en ingles
BACKGROUND: Dyslipidemia is observed among older children and adults with HIV. We examined nonfasting cholesterol and triglycerides in two groups of 12-23-month-old Latin American children - HIV-infected vs. HIV-exposed but uninfected (HEU). METHODS: HIV-infected and HEU children in Latin America and Jamaica were enrolled in an observational cohort. Eligibility for this analysis required having cholesterol and triglyceride results available during the second year of life.
RESULTS:
HIV-infected (n = 83) children were slightly older at the time of lipid testing than the HEU (n = 681). Forty percent of the HIV-infected children were on protease inhibitor-based antiretroviral therapy (ART); 41% were not on ART. There was no statistically significant difference in mean cholesterol concentrations (mg/dl) by HIV status; however, the HIV-infected children had higher mean triglyceride concentrations. The prevalence of high cholesterol (>200 mg/dl) and high triglycerides (>110 mg/dl) was higher among the HIV-infected vs. HEU. Among the HIV-infected children, mean cholesterol and triglyceride concentrations varied by ART. Children receiving no ART had a significantly lower mean cholesterol concentration. Those receiving protease inhibitor-containing ART had a significantly higher mean triglyceride concentration compared to the other two antiretroviral regimen groups.
CONCLUSION:
A greater proportion of HIV-infected children at 12-23 months have hyperlipidemia when compared to HEU children, with the highest triglyceride concentrations observed among those receiving protease inhibitor-containing ART, and the lowest cholesterol levels among those not receiving ART. Implications of these findings will require continued follow-up of HIV-infected children who initiate therapy early in life.
Compartir